Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Tambouret, R; Bell, DA; Centeno, BA
   Significance of histiocytes in cervical smears from peri/postmenopausal women
   DIAGNOSTIC CYTOPATHOLOGY
   
   R. Tambouret et al., "Significance of histiocytes in cervical smears from peri/postmenopausal women", DIAGN CYTOP, 24(4), 2001, pp. 271-275
2. Balen, A
   Polycystic ovary syndrome and cancer
   HUMAN REPRODUCTION UPDATE
   
   A. Balen, "Polycystic ovary syndrome and cancer", HUM REP UPD, 7(6), 2001, pp. 522-525
3. Reis, PDS; Nogueira, AA; dos Reis, FJC; Campolungo, A; Carrara, HHA; de Andrade, JM
   Is hysteroscopic appearance a safe means of differentiating malignant frombenign endometrial polyps in postmenopausal women?
   GYNAECOLOGICAL ENDOSCOPY
   
   P.D.S. Reis et al., "Is hysteroscopic appearance a safe means of differentiating malignant frombenign endometrial polyps in postmenopausal women?", GYNAEC ENDO, 10(1), 2001, pp. 49-51
4. Le Guevel, R; Pakdel, F
   Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods
   APMIS
   
   R. Le Guevel e F. Pakdel, "Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods", APMIS, 109, 2001, pp. S473-S479
5. Diel, P; Smolnikar, K; Schulz, T; Laudenbach-Leschowski, U; Michna, H; Vollmer, G
   Phytoestrogens and carcinogenesis - differential effects of genistein in experimental models of normal and malignant rat endometrium
   APMIS
   
   P. Diel et al., "Phytoestrogens and carcinogenesis - differential effects of genistein in experimental models of normal and malignant rat endometrium", APMIS, 109, 2001, pp. S508-S517
6. Ogawa, S; Koike, T; Shibahara, H; Ohwada, M; Suzuki, M; Araki, S; Sato, I
   Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma - A case report
   GYNECOLOGIC AND OBSTETRIC INVESTIGATION
   
   S. Ogawa et al., "Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma - A case report", GYNECOL OBS, 51(3), 2001, pp. 214-216
7. Foth, D; Nawroth, F; Schmidt, T; Ortmann, M; Romer, T
   Bilateral ovarian fibromas and endometrial adenocarcinoma in a postmenopausal patient with growing uterine myomas
   MATURITAS
   
   D. Foth et al., "Bilateral ovarian fibromas and endometrial adenocarcinoma in a postmenopausal patient with growing uterine myomas", MATURITAS, 39(3), 2001, pp. 259-264
8. Takahashi, M; Nishimura, S; Miyajima, K; Sasahara, K; Yoshida, M; Ando, J; Maekawa, A
   Time-dependent promotion activity of 17 beta-estradiol on uterine carcinogenesis in mice initiated with N-ethyl-N-nitrosourea
   CANCER LETTERS
   
   M. Takahashi et al., "Time-dependent promotion activity of 17 beta-estradiol on uterine carcinogenesis in mice initiated with N-ethyl-N-nitrosourea", CANCER LETT, 165(2), 2001, pp. 123-130
9. Nasu, K; Kai, K; Fujisawa, K; Takai, N; Nishida, Y; Miyakawa, I
   Expression of cathepsin L in normal endometrium and endometrial cancer
   EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
   
   K. Nasu et al., "Expression of cathepsin L in normal endometrium and endometrial cancer", EUR J OB GY, 99(1), 2001, pp. 102-105
10. Diel, P; Smolnikar, K; Schulz, T; Laudenbach-Leschowski, U; Michna, H; Vollmer, G
    Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium
    HUMAN REPRODUCTION
    
    P. Diel et al., "Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium", HUM REPR, 16(5), 2001, pp. 997-1006
11. Le Guevel, R; Pakdel, F
    Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods
    HUMAN REPRODUCTION
    
    R. Le Guevel e F. Pakdel, "Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods", HUM REPR, 16(5), 2001, pp. 1030-1036
12. Otani, T; Minami, S; Yamoto, M; Umesaki, N
    Production of activin A in hyperplasia and adenocarcinoma of the human endometrium
    GYNECOLOGIC ONCOLOGY
    
    T. Otani et al., "Production of activin A in hyperplasia and adenocarcinoma of the human endometrium", GYNECOL ONC, 83(1), 2001, pp. 31-38
13. Roshani, L; Wedekind, D; Szpirer, J; Taib, Z; Szpirer, C; Beckmann, B; Riviere, M; Hedrich, HJ; Klinga-Levan, K
    Genetic identification of multiple susceptibility genes involved in the development of endometrial carcinoma in a rat model
    INTERNATIONAL JOURNAL OF CANCER
    
    L. Roshani et al., "Genetic identification of multiple susceptibility genes involved in the development of endometrial carcinoma in a rat model", INT J CANC, 94(6), 2001, pp. 795-799
14. Strunck, E; Frank, K; Tan, MI; Vollmer, G
    Expression of L-3-phosphoserine phosphatase is regulated by reconstituted basement membrane
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    E. Strunck et al., "Expression of L-3-phosphoserine phosphatase is regulated by reconstituted basement membrane", BIOC BIOP R, 281(3), 2001, pp. 747-753
15. Takehara, K; Kubushiro, K; Iwamori, Y; Tsukazaki, K; Nozawa, S; Iwamori, M
    Expression of an isoform of the testis-specific estrogen sulfotransferase in the murine placenta during the late gestational period
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    
    K. Takehara et al., "Expression of an isoform of the testis-specific estrogen sulfotransferase in the murine placenta during the late gestational period", ARCH BIOCH, 394(2), 2001, pp. 201-208
16. Debus, G; Schuhmacher, I
    Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: a case report
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    
    G. Debus e I. Schuhmacher, "Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: a case report", ACT OBST SC, 80(6), 2001, pp. 589-590
17. Guidos, BJ; Selvaggi, SM
    Detection of endometrial adenocarcinoma with the ThinPreps (R) Pap Test (TM)
    DIAGNOSTIC CYTOPATHOLOGY
    
    B.J. Guidos e S.M. Selvaggi, "Detection of endometrial adenocarcinoma with the ThinPreps (R) Pap Test (TM)", DIAGN CYTOP, 23(4), 2000, pp. 260-265
18. Elagoz, S; Arici, DS; Aker, H
    Relationship between FIGO grade and AgNOR, S100-positive Langerhans cells in endometrial adenocarcinoma
    PATHOLOGY INTERNATIONAL
    
    S. Elagoz et al., "Relationship between FIGO grade and AgNOR, S100-positive Langerhans cells in endometrial adenocarcinoma", PATHOL INT, 50(8), 2000, pp. 616-619
19. Ebert, AD; Wechselberger, C; Martinez-Lacaci, I; Bianco, C; Weitzel, HK; Salomon, DS
    Expression and function of EGF-related peptides and their receptors in gynecological cancer - From basic science to therapy?
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    
    A.D. Ebert et al., "Expression and function of EGF-related peptides and their receptors in gynecological cancer - From basic science to therapy?", J RECEPT SI, 20(1), 2000, pp. 1-46
20. Kaneta, Y; Tsukazaki, K; Kubushiro, K; Sakayori, M; Ueda, M; Nozawa, S
    Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma in vitro and in vivo
    ONCOLOGY REPORTS
    
    Y. Kaneta et al., "Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma in vitro and in vivo", ONCOL REP, 7(5), 2000, pp. 1099-1106
21. Kounelis, S; Kapranos, N; Kouri, E; Coppola, D; Papadaki, H; Jones, MW
    Immunohistochemical profile of endometrial adenocarcinoma: A study of 61 cases and review of the literature
    MODERN PATHOLOGY
    
    S. Kounelis et al., "Immunohistochemical profile of endometrial adenocarcinoma: A study of 61 cases and review of the literature", MOD PATHOL, 13(4), 2000, pp. 379-388
22. Kucera, E; Kainz, C; Reinthaller, A; Sliutz, G; Leodolter, S; Kucera, H; Breitenecker, G
    Accuracy of intraoperative frozen-section diagnosis in stage I endometrialadenocarcinoma
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    E. Kucera et al., "Accuracy of intraoperative frozen-section diagnosis in stage I endometrialadenocarcinoma", GYNECOL OBS, 49(1), 2000, pp. 62-66
23. Gilks, CB; Clement, PB; Hart, WR; Young, RH
    Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: A clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief considerationof adenomyomas of other female genital tract sites
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    C.B. Gilks et al., "Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: A clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief considerationof adenomyomas of other female genital tract sites", INT J GYN P, 19(3), 2000, pp. 195-205
24. Wang, JC; Mes-Masson, AM; Tonin, PN; Provencher, D; Eydoux, P
    Trisomy of chromosome 10 in two cases of ovarian carcinoma
    CANCER GENETICS AND CYTOGENETICS
    
    J.C. Wang et al., "Trisomy of chromosome 10 in two cases of ovarian carcinoma", CANC GENET, 118(1), 2000, pp. 65-68
25. Wheeler, DT; Bell, KA; Kurman, RJ; Sherman, ME
    Minimal uterine serous carcinoma - Diagnosis and clinicopathologic correlation
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    D.T. Wheeler et al., "Minimal uterine serous carcinoma - Diagnosis and clinicopathologic correlation", AM J SURG P, 24(6), 2000, pp. 797-806
26. Sonoda, K; Kaku, T; Hirakawa, T; Kobayashi, H; Amada, S; Sakai, K; Nakashima, M; Watanabe, T; Nakano, H
    The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium
    GYNECOLOGIC ONCOLOGY
    
    K. Sonoda et al., "The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium", GYNECOL ONC, 79(3), 2000, pp. 424-429
27. Soslow, RA; Slomovitz, BM; Saqi, A; Baergen, RN; Caputo, TA
    Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Mullerian serous carcinomas: Clinical divergence without immunophenotypic differences
    GYNECOLOGIC ONCOLOGY
    
    R.A. Soslow et al., "Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Mullerian serous carcinomas: Clinical divergence without immunophenotypic differences", GYNECOL ONC, 79(3), 2000, pp. 430-437
28. Fan, H; Morioka, T; Ito, E
    Induction of apoptosis and growth inhibition of cultured human endometrialadenocarcinoma cells (Sawano) by an antitumor lipoprotein fraction of ricebran
    GYNECOLOGIC ONCOLOGY
    
    H. Fan et al., "Induction of apoptosis and growth inhibition of cultured human endometrialadenocarcinoma cells (Sawano) by an antitumor lipoprotein fraction of ricebran", GYNECOL ONC, 76(2), 2000, pp. 170-175
29. Lavie, O; Hornreich, G; Ben Arie, A; Renbaum, P; Levy-Lahad, E; Beller, U
    BRCA1 germline mutations in women with uterine serous papillary carcinoma
    OBSTETRICS AND GYNECOLOGY
    
    O. Lavie et al., "BRCA1 germline mutations in women with uterine serous papillary carcinoma", OBSTET GYN, 96(1), 2000, pp. 28-32
30. Dadas, B; Basak, T; Ozdemir, T; Polat, N; Turgut, S
    Reliability of frozen section in determining tumor thickness intraoperatively in laryngeal cancer
    LARYNGOSCOPE
    
    B. Dadas et al., "Reliability of frozen section in determining tumor thickness intraoperatively in laryngeal cancer", LARYNGOSCOP, 110(12), 2000, pp. 2070-2073
31. Wang, BY; Kalir, T; Sabo, E; Sherman, DE; Cohen, C; Burstein, DE
    Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia
    CANCER
    
    B.Y. Wang et al., "Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia", CANCER, 88(12), 2000, pp. 2774-2781
32. Sakuragi, N; Takeda, N; Hareyama, H; Fujimoto, T; Todo, Y; Okamoto, K; Takeda, M; Wada, S; Yamamoto, R; Fujimoto, S
    A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma
    CANCER
    
    N. Sakuragi et al., "A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma", CANCER, 88(11), 2000, pp. 2578-2583
33. Chin, AB; Bristow, RE; Korst, LM; Walts, A; Lagasse, LD
    The significance of atypical glandular cells on routine cervical cytologictesting in a community-based population
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    
    A.B. Chin et al., "The significance of atypical glandular cells on routine cervical cytologictesting in a community-based population", AM J OBST G, 182(6), 2000, pp. 1278-1282
34. Muramatsu, T; Yasuda, M; Itoh, J; Kamoshida, S; Hirasama, T; Murakami, M; Shinozuka, T; Osamura, RY; Makino, T
    Immunohistochemical characterization of DU-PAN-2 expression in endometrialadenocarcinomas associated with CA19-9 expression
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    T. Muramatsu et al., "Immunohistochemical characterization of DU-PAN-2 expression in endometrialadenocarcinomas associated with CA19-9 expression", APPL IMMUNO, 7(3), 1999, pp. 173-180
35. Yamamoto, R; Wakui, Y; Taketa, K; Ishikura, H; Sakuragi, N; Hattori, R; Sato, H; Ebina, Y; Nishi, S; Fujimoto, S
    A study on the lectin reactivity of alpha-fetoprotein produced by hepatoidadenocarcinomas and yolk sac tumors
    TUMOR BIOLOGY
    
    R. Yamamoto et al., "A study on the lectin reactivity of alpha-fetoprotein produced by hepatoidadenocarcinomas and yolk sac tumors", TUMOR BIOL, 20(4), 1999, pp. 212-217
36. Giatromanolaki, A; Sivridis, E; Koukourakis, MI; Georgoulias, V; Gatter, KC; Harris, AL
    Intratumoral angiogenesis: A new prognostic indicator for stage I endometrial adenocarcinomas?
    ONCOLOGY RESEARCH
    
    A. Giatromanolaki et al., "Intratumoral angiogenesis: A new prognostic indicator for stage I endometrial adenocarcinomas?", ONCOL RES, 11(4), 1999, pp. 205-212
37. Kotov, A; Falany, JL; Wang, J; Falany, CN
    Regulation of estrogen activity by sulfation in human Ishikawa endometrialadenocarcinoma cells
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    
    A. Kotov et al., "Regulation of estrogen activity by sulfation in human Ishikawa endometrialadenocarcinoma cells", J STEROID B, 68(3-4), 1999, pp. 137-144
38. Heffner, HM; Freedman, AN; Asirwatham, JE; Lele, SB
    Prognostic significance of p53, PCNA, and c-erbB-2 in endometrial adenocarcinoma
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    H.M. Heffner et al., "Prognostic significance of p53, PCNA, and c-erbB-2 in endometrial adenocarcinoma", EUR J GYN O, 20(1), 1999, pp. 8-12
39. Eltabbakh, GH; Moody, J; Garafano, LL; Hammond, JM
    The combination paclitaxel, carboplatin and megestrol acetate is effectivein women with recurrent uterine papillary serous adenocarcinoma
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    G.H. Eltabbakh et al., "The combination paclitaxel, carboplatin and megestrol acetate is effectivein women with recurrent uterine papillary serous adenocarcinoma", EUR J GYN O, 20(1), 1999, pp. 18-19
40. Friedrich, M; Villena-Heinsen, C; Mink, D; Muller, K; Meyberg, R; Woll-Hermann, A; Reitnauer, K; Schmidt, W
    Coincidence of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    M. Friedrich et al., "Coincidence of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma", EUR J GYN O, 20(1), 1999, pp. 29-32
41. Ueda, M; Ueki, M; Terai, Y; Ueki, K; Kumagai, K; Fujii, H; Yoshizawa, K; Nakajima, M
    Biological implications of growth factors on the mechanism of invasion in gynecological tumor cells
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    M. Ueda et al., "Biological implications of growth factors on the mechanism of invasion in gynecological tumor cells", GYNECOL OBS, 48(3), 1999, pp. 221-228
42. Terlikowski, S; Lenczewski, A; Sulkowski, S; Kulikowski, M
    Nucleolar organizer regions in differentiated preneoplastic and neoplasticendometrial lesions
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    S. Terlikowski et al., "Nucleolar organizer regions in differentiated preneoplastic and neoplasticendometrial lesions", GYNECOL OBS, 47(3), 1999, pp. 205-209
43. Bonatz, G; Luttes, J; Hamann, S; Mettler, L; Jonat, W; Parwaresch, R
    Immunohistochemical assessment of p170 provides prognostic information in endometrial carcinoma
    HISTOPATHOLOGY
    
    G. Bonatz et al., "Immunohistochemical assessment of p170 provides prognostic information in endometrial carcinoma", HISTOPATHOL, 34(1), 1999, pp. 43-50
44. Kitamura, T; Nishimura, S; Sasahara, K; Yoshida, M; Ando, J; Takahashi, M; Shirai, T; Maekawa, A
    Transplacental administration of diethylstilbestrol (DES) causes lesions in female reproductive organs of Donryu rats, including endometrial neoplasia
    CANCER LETTERS
    
    T. Kitamura et al., "Transplacental administration of diethylstilbestrol (DES) causes lesions in female reproductive organs of Donryu rats, including endometrial neoplasia", CANCER LETT, 141(1-2), 1999, pp. 219-228
45. Shibahara, H; Shigeta, M; Toji, H; Wakimoto, E; Adachi, S; Ogasawara, T; Takemura, T; Koyama, K
    Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection
    HUMAN REPRODUCTION
    
    H. Shibahara et al., "Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection", HUM REPR, 14(7), 1999, pp. 1908-1911
46. Chetrite, GS; Kloosterboer, HJ; Philippe, JC; Pasqualini, JR
    Effect of Org OD14 (LIVIAL (R)) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines
    ANTICANCER RESEARCH
    
    G.S. Chetrite et al., "Effect of Org OD14 (LIVIAL (R)) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines", ANTICANC R, 19(1A), 1999, pp. 269-275
47. Ayhan, A; Gunalp, S; Karaer, C; Gokoz, A; Oz, U
    Endometrial adenocarcinoma in pregnancy
    GYNECOLOGIC ONCOLOGY
    
    A. Ayhan et al., "Endometrial adenocarcinoma in pregnancy", GYNECOL ONC, 75(2), 1999, pp. 298-299
48. Anderson, PS; Smith, HO; Jones, JG; Goldberg, GL; Fields, AL; Runowicz, CD; Pollard, JW
    Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas
    GYNECOLOGIC ONCOLOGY
    
    P.S. Anderson et al., "Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas", GYNECOL ONC, 74(2), 1999, pp. 202-207
49. Mohan, DS; Samuels, MA
    To the editor - Reply
    GYNECOLOGIC ONCOLOGY
    
    D.S. Mohan e M.A. Samuels, "To the editor - Reply", GYNECOL ONC, 73(3), 1999, pp. 465-467
50. NGUYEN TN; BOURDEAU JL; FERENCZY A; FRANCO EL
    CLINICAL-SIGNIFICANCE OF HISTIOCYTES IN THE DETECTION OF ENDOMETRIAL ADENOCARCINOMA AND HYPERPLASIA
    Diagnostic cytopathology
    
    T.N. Nguyen et al., "CLINICAL-SIGNIFICANCE OF HISTIOCYTES IN THE DETECTION OF ENDOMETRIAL ADENOCARCINOMA AND HYPERPLASIA", Diagnostic cytopathology, 19(2), 1998, pp. 89-93
51. Leveque, J; Goyat, F; Dugast, J; Loeillet, L; Grall, JY; Le Bars, S
    Value the peritoneal cytology after hysteroscopy in surgical stage I adenocarcinoma of the endometrium
    CONTRACEPTION FERTILITE SEXUALITE
    
    J. Leveque et al., "Value the peritoneal cytology after hysteroscopy in surgical stage I adenocarcinoma of the endometrium", CONTR FER S, 26(12), 1998, pp. 865-868
52. CHAMBERS JT; RUTHERFORD TJ; BAKER L; KOHORN EI; SCHWARTZ PE; CARCANGIU ML; CHAMBERS SK
    SEROUS CARCINOMA OF THE UTERUS TREATED WITH CISPLATIN, DOXORUBICIN AND ETOPOSIDE
    International journal of gynecological cancer
    
    J.T. Chambers et al., "SEROUS CARCINOMA OF THE UTERUS TREATED WITH CISPLATIN, DOXORUBICIN AND ETOPOSIDE", International journal of gynecological cancer, 8(3), 1998, pp. 193-196
53. UGWUMADU AHN; CARMICHAEL PL; NEVEN P
    TAMOXIFEN AND THE FEMALE GENITAL-TRACT
    International journal of gynecological cancer
    
    A.H.N. Ugwumadu et al., "TAMOXIFEN AND THE FEMALE GENITAL-TRACT", International journal of gynecological cancer, 8(1), 1998, pp. 6-15
54. PECORELLI S; FALLO L
    HORMONE REPLACEMENT THERAPY IN GYNECOLOGICAL CANCER SURVIVORS
    Critical reviews in oncology/hematology
    
    S. Pecorelli e L. Fallo, "HORMONE REPLACEMENT THERAPY IN GYNECOLOGICAL CANCER SURVIVORS", Critical reviews in oncology/hematology, 27(1), 1998, pp. 1-10
55. LEVEQUE J; GOYAT F; DUGAST J; LOEILLET L; GRALL JY; LEBARS S
    VALUE OF PERITONEAL CYTOLOGY AFTER HYSTEROSCOPY IN SURGICAL STAGE-I ADENOCARCINOMA OF THE ENDOMETRIUM
    Oncology Reports
    
    J. Leveque et al., "VALUE OF PERITONEAL CYTOLOGY AFTER HYSTEROSCOPY IN SURGICAL STAGE-I ADENOCARCINOMA OF THE ENDOMETRIUM", Oncology Reports, 5(3), 1998, pp. 713-715
56. Seppanen, M; Henttinen, T; Lin, L; Punnonen, J; Grenman, S; Punnonen, R; Vihko, KK
    Inhibitory effects of cytokines on ovarian and endometrial carcinoma cellsin vitro with special reference to induction of specific transcriptional regulators
    ONCOLOGY RESEARCH
    
    M. Seppanen et al., "Inhibitory effects of cytokines on ovarian and endometrial carcinoma cellsin vitro with special reference to induction of specific transcriptional regulators", ONCOL RES, 10(11-12), 1998, pp. 575-589
57. DEXEUS S; BARRI PN
    HYPERPROLACTINEMIA - AN INDUCTOR OF NEOPLASTIC CHANGES IN ENDOMETRIUM- A REPORT OF 2 CASES
    Gynecological endocrinology
    
    S. Dexeus e P.N. Barri, "HYPERPROLACTINEMIA - AN INDUCTOR OF NEOPLASTIC CHANGES IN ENDOMETRIUM- A REPORT OF 2 CASES", Gynecological endocrinology, 12(4), 1998, pp. 273-275
58. KANETA Y; TSUKAZAKI K; KUBUSHIRO K; AOKI R; SAKAYORI M; UEDA M; NOZAWA S
    EFFECT OF GELONIN IMMUNOCONJUGATE WITH MONOCLONAL-ANTIBODY MSN-1 TO ENDOMETRIAL ADENOCARCINOMA ON ANTIGEN-PRODUCING TUMOR-CELLS IN-VIVO
    Japanese journal of cancer research
    
    Y. Kaneta et al., "EFFECT OF GELONIN IMMUNOCONJUGATE WITH MONOCLONAL-ANTIBODY MSN-1 TO ENDOMETRIAL ADENOCARCINOMA ON ANTIGEN-PRODUCING TUMOR-CELLS IN-VIVO", Japanese journal of cancer research, 89(5), 1998, pp. 583-588
59. SEKI A; NAKAMURA K; KODAMA J; MIYAGI Y; YOSHINOUCHI M; KUDO T
    A CLOSE CORRELATION BETWEEN C-ERBB-2 GENE AMPLIFICATION AND LOCAL PROGRESSION IN ENDOMETRIAL ADENOCARCINOMA
    European journal of gynaecological oncology
    
    A. Seki et al., "A CLOSE CORRELATION BETWEEN C-ERBB-2 GENE AMPLIFICATION AND LOCAL PROGRESSION IN ENDOMETRIAL ADENOCARCINOMA", European journal of gynaecological oncology, 19(1), 1998, pp. 90-92
60. FRIEDRICH M; MINK D; VILLENAHEINSEN C; WOLLHERMANN A; SCHMIDT W
    TAMOXIFEN AND PROLIFERATION OF VAGINAL AND CERVICAL EPITHELIUM IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
    European journal of obstetrics, gynecology, and reproductive biology
    
    M. Friedrich et al., "TAMOXIFEN AND PROLIFERATION OF VAGINAL AND CERVICAL EPITHELIUM IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER", European journal of obstetrics, gynecology, and reproductive biology, 80(2), 1998, pp. 221-225
61. SUGIYAMA T; OHTA S; NISHIDA T; OKURA N; TANABE K; YAKUSHIJI M
    2 CASES OF ENDOMETRIAL ADENOCARCINOMA ARISING FROM ATYPICAL POLYPOID ADENOMYOMA
    Gynecologic oncology (Print)
    
    T. Sugiyama et al., "2 CASES OF ENDOMETRIAL ADENOCARCINOMA ARISING FROM ATYPICAL POLYPOID ADENOMYOMA", Gynecologic oncology (Print), 71(1), 1998, pp. 141-144
62. IOFFE OB; PAPADIMITRIOU JC; DRACHENBERG CB
    CORRELATION OF PROLIFERATION INDEXES, APOPTOSIS, AND RELATED ONCOGENEEXPRESSION (BCL-2 AND C-ERBB-2) AND P53 IN PROLIFERATIVE, HYPERPLASTIC, AND MALIGNANT ENDOMETRIUM
    Human pathology
    
    O.B. Ioffe et al., "CORRELATION OF PROLIFERATION INDEXES, APOPTOSIS, AND RELATED ONCOGENEEXPRESSION (BCL-2 AND C-ERBB-2) AND P53 IN PROLIFERATIVE, HYPERPLASTIC, AND MALIGNANT ENDOMETRIUM", Human pathology, 29(10), 1998, pp. 1150-1159
63. Mazurek, A; Telego, M; Pierzynski, P; Lapuc, G; Niklinska, W; Juczewska, M; Chyczewski, L
    Angiogenesis in endometrial cancer
    NEOPLASMA
    
    A. Mazurek et al., "Angiogenesis in endometrial cancer", NEOPLASMA, 45(6), 1998, pp. 360-364
64. TREECK O; STRUNCK E; VOLLMER G
    A NOVEL BASEMENT MEMBRANE-INDUCED GENE IDENTIFIED IN THE HUMAN ENDOMETRIAL ADENOCARCINOMA CELL-LINE HEC1B
    FEBS letters
    
    O. Treeck et al., "A NOVEL BASEMENT MEMBRANE-INDUCED GENE IDENTIFIED IN THE HUMAN ENDOMETRIAL ADENOCARCINOMA CELL-LINE HEC1B", FEBS letters, 425(3), 1998, pp. 426-430
65. OHWADA M; SUZUKI M; OHNO T; SAITO K; SATO I
    APPEARANCE OF PRIMARY ENDOMETRIAL AND OVARIAN CLEAR-CELL ADENOCARCINOMA 17 MONTHS POSTPARTUM - A CASE-REPORT
    Acta cytologica
    
    M. Ohwada et al., "APPEARANCE OF PRIMARY ENDOMETRIAL AND OVARIAN CLEAR-CELL ADENOCARCINOMA 17 MONTHS POSTPARTUM - A CASE-REPORT", Acta cytologica, 42(3), 1998, pp. 765-768
66. COUCHMAN GM; BENTLEY R; TSAO MS; RASZMANN K; MCLACHLAN JA; WALMER DK
    P53(LYN) AND P56(LYN) - A NEW SIGNALING PATHWAY IN HUMAN ENDOMETRIUM AND ENDOMETRIAL ADENOCARCINOMAS
    Journal of the Society for Gynecologic Investigation
    
    G.M. Couchman et al., "P53(LYN) AND P56(LYN) - A NEW SIGNALING PATHWAY IN HUMAN ENDOMETRIUM AND ENDOMETRIAL ADENOCARCINOMAS", Journal of the Society for Gynecologic Investigation, 4(2), 1997, pp. 103-109
67. KANETA Y; TSUKAZAKI K; KUBUSHIRO K; AOKI R; SAKAYORI M; UEDA M; NOZAWA S
    EFFECTS OF GELONIN IMMUNOCONJUGATE OF MONOCLONAL-ANTIBODY MSN-1 TO ENDOMETRIAL ADENOCARCINOMA ON ANTIGEN-PRODUCING TUMOR-CELLS IN-VITRO
    Oncology Reports
    
    Y. Kaneta et al., "EFFECTS OF GELONIN IMMUNOCONJUGATE OF MONOCLONAL-ANTIBODY MSN-1 TO ENDOMETRIAL ADENOCARCINOMA ON ANTIGEN-PRODUCING TUMOR-CELLS IN-VITRO", Oncology Reports, 4(2), 1997, pp. 331-336
68. KARLSSON L; DELLE U; HORVATH G
    SHORT-TREM AND LONG-TERM ESTRADIOL TREATMENT INHIBITS GROWTH AND ALTERS EXPRESSION OF P21(WAF1 CIP1) IN AN ENDOMETRIAL ADENOCARCINOMA CELL-LINE LACKING FUNCTIONAL P53/
    European journal of cancer
    
    L. Karlsson et al., "SHORT-TREM AND LONG-TERM ESTRADIOL TREATMENT INHIBITS GROWTH AND ALTERS EXPRESSION OF P21(WAF1 CIP1) IN AN ENDOMETRIAL ADENOCARCINOMA CELL-LINE LACKING FUNCTIONAL P53/", European journal of cancer, 33(13), 1997, pp. 2252-2257
69. HORDING U; DAUGAARD S; VISFELDT J
    ADENOCARCINOMA OF THE CERVIX AND ADENOCARCINOMA OF THE ENDOMETRIUM - DISTINCTION WITH PCR-MEDIATED DETECTION OF HPV DNA
    APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    
    U. Hording et al., "ADENOCARCINOMA OF THE CERVIX AND ADENOCARCINOMA OF THE ENDOMETRIUM - DISTINCTION WITH PCR-MEDIATED DETECTION OF HPV DNA", APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 105(4), 1997, pp. 313-316
70. SHEETS EE; YEH J
    THE ROLE OF APOPTOSIS IN GYNECOLOGICAL MALIGNANCIES
    Annals of medicine
    
    E.E. Sheets e J. Yeh, "THE ROLE OF APOPTOSIS IN GYNECOLOGICAL MALIGNANCIES", Annals of medicine, 29(2), 1997, pp. 121-126
71. MILLER WR; LANGDON SP
    STEROID-HORMONES AND CANCER .3. OBSERVATIONS FROM HUMAN-SUBJECTS
    European journal of surgical oncology
    
    W.R. Miller e S.P. Langdon, "STEROID-HORMONES AND CANCER .3. OBSERVATIONS FROM HUMAN-SUBJECTS", European journal of surgical oncology, 23(2), 1997, pp. 163-177
72. SENZAKI H; OSAKI T; UEMURA Y; KIYOZUKA Y; OGURA E; OKAMURA A; TSUBURA A
    ADENOID BASAL CARCINOMA OF THE UTERINE CERVIX - IMMUNOHISTOCHEMICAL STUDY AND LITERATURE-REVIEW
    Japanese Journal of Clinical Oncology
    
    H. Senzaki et al., "ADENOID BASAL CARCINOMA OF THE UTERINE CERVIX - IMMUNOHISTOCHEMICAL STUDY AND LITERATURE-REVIEW", Japanese Journal of Clinical Oncology, 27(6), 1997, pp. 437-441
73. OBWEGESER R; AUERBACH L; KUBISTA E
    GYNECOLOGICAL ASPECTS OF TAMOXIFEN TREATMENT IN BREAST-CANCER PATIENTS
    Cancer treatment reviews
    
    R. Obwegeser et al., "GYNECOLOGICAL ASPECTS OF TAMOXIFEN TREATMENT IN BREAST-CANCER PATIENTS", Cancer treatment reviews, 23(5-6), 1997, pp. 289-304
74. VERMES A; GUCHELAAR HJ; KOOPMANS RP
    INDIVIDUALIZATION OF CANCER-THERAPY BASED ON CYTOCHROME-P450 POLYMORPHISM - A PHARMACOGENETIC APPROACH
    Cancer treatment reviews
    
    A. Vermes et al., "INDIVIDUALIZATION OF CANCER-THERAPY BASED ON CYTOCHROME-P450 POLYMORPHISM - A PHARMACOGENETIC APPROACH", Cancer treatment reviews, 23(5-6), 1997, pp. 321-339
75. TAKAMI M; SAKAMOTO H; OHTANI K; TAKAMI T; SATOH K
    AN EVALUATION OF CA125 LEVELS IN 291 NORMAL POSTMENOPAUSAL AND 20 ENDOMETRIAL ADENOCARCINOMA-BEARING WOMEN BEFORE AND AFTER SURGERY
    Cancer letters
    
    M. Takami et al., "AN EVALUATION OF CA125 LEVELS IN 291 NORMAL POSTMENOPAUSAL AND 20 ENDOMETRIAL ADENOCARCINOMA-BEARING WOMEN BEFORE AND AFTER SURGERY", Cancer letters, 121(1), 1997, pp. 69-72
76. SALHA O; MARTINHIRSCH P; LANE G; SHARMA V
    ENDOMETRIAL CARCINOMA IN A YOUNG PATIENT WITH POLYCYSTIC OVARIAN SYNDROME - FIRST SUSPECTED AT TIME OF EMBRYO-TRANSFER
    Human reproduction
    
    O. Salha et al., "ENDOMETRIAL CARCINOMA IN A YOUNG PATIENT WITH POLYCYSTIC OVARIAN SYNDROME - FIRST SUSPECTED AT TIME OF EMBRYO-TRANSFER", Human reproduction, 12(5), 1997, pp. 959-962
77. KUWASHIMA Y; KOBAYASHI Y; KUROSUMI M; TANUMA J; SHIROMIZU K; KISHI K
    INVERSE CORRELATION BETWEEN BCL-2 EXPRESSION AND CELL-GROWTH FRACTIONIN HUMAN ENDOMETRIAL ADENOCARCINOMA TISSUE
    Anticancer research
    
    Y. Kuwashima et al., "INVERSE CORRELATION BETWEEN BCL-2 EXPRESSION AND CELL-GROWTH FRACTIONIN HUMAN ENDOMETRIAL ADENOCARCINOMA TISSUE", Anticancer research, 17(5B), 1997, pp. 3773-3776
78. BONACCORSI L; LUCONI M; MAGGI M; MURATORI M; FORTI G; SERIO M; BALDI E
    PROTEIN-TYROSINE KINASE, MITOGEN-ACTIVATED PROTEIN-KINASE AND PROTEIN-KINASE-C ARE INVOLVED IN THE MITOGENIC SIGNALING OF PLATELET-ACTIVATING-FACTOR (PAF) IN HEC-1A CELLS
    Biochimica et biophysica acta. Molecular cell research
    
    L. Bonaccorsi et al., "PROTEIN-TYROSINE KINASE, MITOGEN-ACTIVATED PROTEIN-KINASE AND PROTEIN-KINASE-C ARE INVOLVED IN THE MITOGENIC SIGNALING OF PLATELET-ACTIVATING-FACTOR (PAF) IN HEC-1A CELLS", Biochimica et biophysica acta. Molecular cell research, 1355(2), 1997, pp. 155-166
79. PIROG EC; HELLER DS; WESTHOFF C
    ENDOMETRIAL ADENOCARCINOMA - LACK OF CORRELATION BETWEEN TREATMENT DELAY AND TUMOR STAGE
    Gynecologic oncology
    
    E.C. Pirog et al., "ENDOMETRIAL ADENOCARCINOMA - LACK OF CORRELATION BETWEEN TREATMENT DELAY AND TUMOR STAGE", Gynecologic oncology, 67(3), 1997, pp. 303-308
80. SINGER S; ROSENBERG AE; KATTAPURAM SV; GOODMAN A; LIETMAN SA
    A 54-YEAR-OLD DIABETIC WOMAN WITH PAIN AND SWELLING OF THE LEG - SKELETAL-MUSCLE INFARCTION ASSOCIATED WITH DIABETES-MELLITUS
    The New England journal of medicine
    
    S. Singer et al., "A 54-YEAR-OLD DIABETIC WOMAN WITH PAIN AND SWELLING OF THE LEG - SKELETAL-MUSCLE INFARCTION ASSOCIATED WITH DIABETES-MELLITUS", The New England journal of medicine, 337(12), 1997, pp. 839-845
81. KHALIFA MA; PATTERSONCOBBS G; HANSEN CH; HINES JF; JOHNSON JC
    THE OCCURRENCE OF ENDOMETRIAL ADENOCARCINOMA IN A PATIENT WITH BASAL-CELL NEVUS SYNDROME
    Journal of the National Medical Association
    
    M.A. Khalifa et al., "THE OCCURRENCE OF ENDOMETRIAL ADENOCARCINOMA IN A PATIENT WITH BASAL-CELL NEVUS SYNDROME", Journal of the National Medical Association, 89(8), 1997, pp. 549-552
82. MARKOGIANNAKIS E; GEORGOULIAS V; MARGIORIS AN; ZOUMAKIS E; STOURNARAS C; GRAVANIS A
    ESTROGENS AND GLUCOCORTICOIDS INDUCE THE EXPRESSION OF C-ERBB2 NEU RECEPTOR IN ISHIKAWA HUMAN ENDOMETRIAL CELLS/
    Life sciences
    
    E. Markogiannakis et al., "ESTROGENS AND GLUCOCORTICOIDS INDUCE THE EXPRESSION OF C-ERBB2 NEU RECEPTOR IN ISHIKAWA HUMAN ENDOMETRIAL CELLS/", Life sciences, 61(11), 1997, pp. 1083-1095
83. EIFEL PJ
    INTRACAVITARY BRACHYTHERAPY IN THE TREATMENT OF GYNECOLOGIC NEOPLASMS
    Journal of surgical oncology
    
    P.J. Eifel, "INTRACAVITARY BRACHYTHERAPY IN THE TREATMENT OF GYNECOLOGIC NEOPLASMS", Journal of surgical oncology, 66(2), 1997, pp. 141-147
84. SIEGFRIED S; PEKONEN F; NYMAN T; AMMALA M; RUTANEN EM
    DISTINCT PATTERNS OF EXPRESSION OF KERATINOCYTE GROWTH-FACTOR AND ITSRECEPTOR IN ENDOMETRIAL CARCINOMA
    Cancer
    
    S. Siegfried et al., "DISTINCT PATTERNS OF EXPRESSION OF KERATINOCYTE GROWTH-FACTOR AND ITSRECEPTOR IN ENDOMETRIAL CARCINOMA", Cancer, 79(6), 1997, pp. 1166-1171
85. KATSUKI Y; SHIBUTANI Y; AOKI D; NOZAWA S
    DIENOGEST, A NOVEL SYNTHETIC STEROID, OVERCOMES HORMONE-DEPENDENT CANCER IN A DIFFERENT MANNER THAN PROGESTINS
    Cancer
    
    Y. Katsuki et al., "DIENOGEST, A NOVEL SYNTHETIC STEROID, OVERCOMES HORMONE-DEPENDENT CANCER IN A DIFFERENT MANNER THAN PROGESTINS", Cancer, 79(1), 1997, pp. 169-176
86. RIBATTI D; VACCA A; GASPARINI G; LOVERRO G; DIVAGNO G; IURLARO M; LOTESORIERE C; RONCALI L; SELVAGGI L
    ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CARCINOMA INDUCE A VASOPROLIFERATIVE RESPONSE IN THE CHICK-EMBRYO CHORIOALLANTOIC MEMBRANE
    International journal of oncology
    
    D. Ribatti et al., "ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CARCINOMA INDUCE A VASOPROLIFERATIVE RESPONSE IN THE CHICK-EMBRYO CHORIOALLANTOIC MEMBRANE", International journal of oncology, 8(6), 1996, pp. 1149-1153
87. KOYAMA Y; TAKETA K; AZUMA M; YAMAMOTO R; FUJIMOTO S; NISHI S
    BIOCHEMICAL-CHARACTERIZATION OF ALPHA-FETOPROTEIN AND OTHER SERUM-PROTEINS PRODUCED BY A UTERINE ENDOMETRIAL ADENOCARCINOMA
    Japanese journal of cancer research
    
    Y. Koyama et al., "BIOCHEMICAL-CHARACTERIZATION OF ALPHA-FETOPROTEIN AND OTHER SERUM-PROTEINS PRODUCED BY A UTERINE ENDOMETRIAL ADENOCARCINOMA", Japanese journal of cancer research, 87(6), 1996, pp. 612-617
88. SANANES S; KHAIRALLAH T; TOUBOUL E; SALATBAROUX J; UZAN S
    FOLLOW-UP OF WOMEN TREATED WITH TAMOXIFEN
    La Presse medicale
    
    S. Sananes et al., "FOLLOW-UP OF WOMEN TREATED WITH TAMOXIFEN", La Presse medicale, 25(10), 1996, pp. 499-502
89. KOVACS AG; CSERNI G
    ENDOMETRIAL ADENOCARCINOMA IN EARLY-PREGNANCY
    Gynecologic and obstetric investigation
    
    A.G. Kovacs e G. Cserni, "ENDOMETRIAL ADENOCARCINOMA IN EARLY-PREGNANCY", Gynecologic and obstetric investigation, 41(1), 1996, pp. 70-72
90. TAKAHASHI M; IIJIMA T; SUZUKI K; ANDOLU J; YOSHIDA M; KITAMURA T; NISHIYAMA K; MIYAJIMA K; MAEKAWA A
    RAPID AND HIGH-YIELD INDUCTION OF ENDOMETRIAL ADENOCARCINOMAS IN CD-1MICE BY A SINGLE INTRAUTERINE ADMINISTRATION OF N-ETHYL-N-NITROSOUREACOMBINED WITH CHRONIC 17-BETA-ESTRADIOL TREATMENT
    Cancer letters
    
    M. Takahashi et al., "RAPID AND HIGH-YIELD INDUCTION OF ENDOMETRIAL ADENOCARCINOMAS IN CD-1MICE BY A SINGLE INTRAUTERINE ADMINISTRATION OF N-ETHYL-N-NITROSOUREACOMBINED WITH CHRONIC 17-BETA-ESTRADIOL TREATMENT", Cancer letters, 104(1), 1996, pp. 7-12
91. WOO HL; SWENERTON KD; HOSKINS PJ
    TAXOL IS ACTIVE IN PLATINUM-RESISTANT ENDOMETRIAL ADENOCARCINOMA
    American journal of clinical oncology
    
    H.L. Woo et al., "TAXOL IS ACTIVE IN PLATINUM-RESISTANT ENDOMETRIAL ADENOCARCINOMA", American journal of clinical oncology, 19(3), 1996, pp. 290-291
92. KONSKI AA; DOMENICO D; IRVING D; TYRKUS M; NEISLER J; PHIBBS G; MAH J; EGGLESTON W
    CLINICOPATHOLOGICAL CORRELATION OF DNA FLOW CYTOMETRIC CONTENT-ANALYSIS (DFCA), SURGICAL STAGING, AND ESTROGEN PROGESTERONE RECEPTOR STATUSIN ENDOMETRIAL ADENOCARCINOMA/
    American journal of clinical oncology
    
    A.A. Konski et al., "CLINICOPATHOLOGICAL CORRELATION OF DNA FLOW CYTOMETRIC CONTENT-ANALYSIS (DFCA), SURGICAL STAGING, AND ESTROGEN PROGESTERONE RECEPTOR STATUSIN ENDOMETRIAL ADENOCARCINOMA/", American journal of clinical oncology, 19(2), 1996, pp. 164-168
93. KUWASHIMA Y; KOBAYASHI Y; KAWARAI A; KUROSUMI M; TANUMA J; SHIROMIZU K; MATSUZAWA M; KISHI K
    EVALUATION OF APOPTOSIS IN HUMAN ENDOMETRIAL ADENOCARCINOMA - COMPARISON OF NICK END LABELING AND LE(Y) ANTIGEN IMMUNOSTAINING METHOD
    Anticancer research
    
    Y. Kuwashima et al., "EVALUATION OF APOPTOSIS IN HUMAN ENDOMETRIAL ADENOCARCINOMA - COMPARISON OF NICK END LABELING AND LE(Y) ANTIGEN IMMUNOSTAINING METHOD", Anticancer research, 16(5B), 1996, pp. 3225-3228
94. KAUNITZ AM
    DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION AND THE RISK OF BREAST AND GYNECOLOGIC CANCER
    Journal of reproductive medicine
    
    A.M. Kaunitz, "DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION AND THE RISK OF BREAST AND GYNECOLOGIC CANCER", Journal of reproductive medicine, 41(5), 1996, pp. 419-425
95. YAMAMOTO R; ISHIKURA H; AZUMA M; HAREYAMA H; MAKINODA S; KOYAMA Y; NISHI S; FUJIMOTO S
    ALPHA-FETOPROTEIN PRODUCTION BY A HEPATOID ADENOCARCINOMA OF THE UTERUS
    Journal of Clinical Pathology
    
    R. Yamamoto et al., "ALPHA-FETOPROTEIN PRODUCTION BY A HEPATOID ADENOCARCINOMA OF THE UTERUS", Journal of Clinical Pathology, 49(5), 1996, pp. 420-422
96. DEHAL SS; KUPFER D
    EVIDENCE THAT THE CATECHOL 3,4-DIHYDROXYTAMOXIFEN IS A PROXIMATE INTERMEDIATE TO THE REACTIVE SPECIES BINDING COVALENTLY TO PROTEINS
    Cancer research
    
    S.S. Dehal e D. Kupfer, "EVIDENCE THAT THE CATECHOL 3,4-DIHYDROXYTAMOXIFEN IS A PROXIMATE INTERMEDIATE TO THE REACTIVE SPECIES BINDING COVALENTLY TO PROTEINS", Cancer research, 56(6), 1996, pp. 1283-1290
97. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
    EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY
    Cancer
    
    G.B. Kristensen et al., "EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY", Cancer, 78(3), 1996, pp. 433-440
98. CODEGONI AM; LANDONI F; LOMONICO S; LOSA G; MANGIONI C; TAVERNA M; LUCCHINI V; DINCALCI M
    INTERFERON-BETA CAN INDUCE PROGESTERONE RECEPTORS IN HUMAN ENDOMETRIAL ADENOCARCINOMA
    Cancer
    
    A.M. Codegoni et al., "INTERFERON-BETA CAN INDUCE PROGESTERONE RECEPTORS IN HUMAN ENDOMETRIAL ADENOCARCINOMA", Cancer, 78(3), 1996, pp. 448-453
99. SONODA K; NAKASHIMA M; KAKU T; KAMURA T; NAKANO H; WATANABE T
    A NOVEL TUMOR-ASSOCIATED ANTIGEN EXPRESSED IN HUMAN UTERINE AND OVARIAN CARCINOMAS
    Cancer
    
    K. Sonoda et al., "A NOVEL TUMOR-ASSOCIATED ANTIGEN EXPRESSED IN HUMAN UTERINE AND OVARIAN CARCINOMAS", Cancer, 77(8), 1996, pp. 1501-1509
100. LOSCH A; KOHLBERGER P; GITSCH G; KAIDER A; BREITENECKER G; KAINZ C
     LYSOSOMAL PROTEASE CATHEPSIN-D IS A PROGNOSTIC MARKER IN ENDOMETRIAL CANCER
     British Journal of Cancer
     
     A. Losch et al., "LYSOSOMAL PROTEASE CATHEPSIN-D IS A PROGNOSTIC MARKER IN ENDOMETRIAL CANCER", British Journal of Cancer, 73(12), 1996, pp. 1525-1528